EPA and DHA supplementation

( DrugBank: - / KEGG DRUG: - )


2 diseases
IDDisease name (Link within this page)Number of trials
48Primary antiphospholipid syndrome1
IDDisease name (Link within this page)Number of trials
49Systemic lupus erythematosus1

48. Primary antiphospholipid syndrome


Clinical trials : 9Drugs : 8 - (DrugBank : 6) / Drug target genes : 3 - Drug target pathways : 59 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

49. Systemic lupus erythematosus


Clinical trials : 1,227Drugs : 752 - (DrugBank : 175) / Drug target genes : 130 - Drug target pathways : 207 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries